Vimarsana
Biggest News Aggregation in the World

Febuxostat Tablets News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Febuxostat Tablets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Febuxostat Tablets Today - Breaking & Trending Today

Stocks to Watch: Indigo, Adani Ent, HDFC Bank, RIL, Zee Ent, RVNL, and Others - Vimarsana News

Stocks to Watch: Indigo, Adani Ent, HDFC Bank, RIL, Zee Ent, RVNL, and Others

Stocks to watch: Shares of firms like Indigo, Adani Ent, HDFC Bank, RIL, Zee Ent, RVNL, and others will be in focus on Monday's trade.

Source: news18.com
Stocks to Monitor: Adani Enterprises, Indigo, HDFC Bank, RIL, Sun Pharma, ZEE - Vimarsana News

Stocks to Monitor: Adani Enterprises, Indigo, HDFC Bank, RIL, Sun Pharma, ZEE

The Indian stock market indices, Sensex and Nifty, are expected to begin trading on a slow note due to weak...

Sun Pharma recalls 55,000 bottles of generic drug from US market due to manufacturing norms violation - Vimarsana News

Sun Pharma recalls 55,000 bottles of generic drug from US market due to manufacturing norms violation

Sun Pharma is recalling 55,000 bottles of Febuxostat Tablets, in 40 mg and 80 mg strengths, from the American market due to manufacturing practice deviations caused by microbial contamination at their Dadra-based plant.

Why Sun Pharma is recalling 55,000 bottles of generic gout medication from US? - Vimarsana News

Why Sun Pharma is recalling 55,000 bottles of generic gout medication from US?

Sun Pharma recalls Febuxostat Tablets in 40 mg and 80 mg strengths from US market.

Sun Pharma recalls 55,000 bottles of generic drug from US market; here's why - Vimarsana News

Sun Pharma recalls 55,000 bottles of generic drug from US market; here's why

The New Jersey-based unit of the Mumbai-based drug major is recalling Febuxostat Tablets in 40 mg and 80 mg strengths, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report.